Evidence map›Paper›PMID 35292786›Full record

ArticleActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2022

Relationship of

Orhan Asya, Ali Cemal Yumuşakhuylu, Pelin Bağcı, Handan Kaya, Ayşegül Gönen, Yavuz Gündoğdu, Tajaddın Muradov, Akın Şahin, Çağatay Oysu

Open access · goldAbstract read
In one paragraph

Article in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Orhan AsyaDepartment of Otolaryngology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Ali Cemal YumuşakhuyluDepartment of Otolaryngology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Pelin BağcıDepartment of Pathology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Handan KayaDepartment of Pathology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Ayşegül GönenDepartment of Otolaryngology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Yavuz GündoğduDepartment of Otolaryngology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Tajaddın MuradovDepartment of Otolaryngology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Akın ŞahinDepartment of Otolaryngology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Çağatay OysuDepartment of Otolaryngology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Marmara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Methods: Immunohistochemical analysis of Results: Conclusion:

Indexed as

PPAR gammaThyroid NeoplasmsHumansPrognosisThyroid Cancer, PapillaryPPAR gammaPPARG protein, humanpapillary thyroid carcinomaPAX8/PPARG fusion protein (PPFP)pioglitazoneprognostic parameters

Identifiers

PMID35292786
PMCPMC9058936
OpenAlexW4220671402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.